Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives

SIMPLE SUMMARY: Medulloblastoma (MB) is a primary brain tumor and is one of the most prevalent neoplasms in the pediatric age group, with a median age of diagnosis of six years. Besides the symptoms that can accompany BM tumors, conventional therapy involving surgical resection, radiotherapy and che...

Descripción completa

Detalles Bibliográficos
Autores principales: Voskamp, Marije J., Li, Shuang, van Daalen, Kim R., Crnko, Sandra, ten Broeke, Toine, Bovenschen, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582409/
https://www.ncbi.nlm.nih.gov/pubmed/34771550
http://dx.doi.org/10.3390/cancers13215387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582409/
https://www.ncbi.nlm.nih.gov/pubmed/34771550
http://dx.doi.org/10.3390/cancers13215387

Ejemplares similares